TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31365441

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Higher BMI and hemoglobin A1C levels
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Gender differences in smoking history
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Age group comparison (50 years or younger vs older than 50 years)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Total cholesterol levels
Number of subjects: 100
Study: 28803691

Group type: EXPERIMENTAL
Intervention: Topical lavender oil ointment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Night wrist orthotic and placebo ointment
Number of subjects: 48
Study: 27243899

Group type: EXPERIMENTAL
Intervention: Mobility Program (MP) - assisted ambulation up to twice daily with a behavioral strategy to encourage mobility.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual Care (UC) - received twice-daily visits.
Number of subjects: 100
Study: 26580884

Group type: EXPERIMENTAL
Intervention: Dual-wavelength laser system (595-nm PDL combined with 1,064-nm Nd:YAG laser)
Number of subjects: 16
Study: 23472071

Group type: EXPERIMENTAL
Intervention: 1% vaginal tenofovir gel
Number of subjects: 868
Study: 19661957

Group type: EXPERIMENTAL
Intervention: Instructor-led intervention (ILI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Self-help (SH)
Number of subjects: 60
Study: 18801383

Group type: EXPERIMENTAL
Intervention: Aligned Fourier phase in different regions of the face frequency spectrum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed signal‐to‐noise ratio of phase alignment within a contiguous range of face frequencies
Number of subjects: 0
Study: 15872361

Group type: EXPERIMENTAL
Intervention: Postacquisition subtraction of a low-noise random coincidence estimate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Real-time subtraction of a delayed coincidence channel
Number of subjects: 0
Study: 12809830

Group type: EXPERIMENTAL
Intervention: Rifaximin 600 mg per day
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Rifaximin 1200 mg per day
Number of subjects: 380

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Rifaximin (both doses)
Number of subjects: 380
Study: 10793453

Group type: EXPERIMENTAL
Intervention: Ethylene oxide (EO) sterilization management practices in medical institutions
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ethylene oxide (EO) sterilization activities in hospitals
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ethylene oxide (EO) sterilization activities in clinics
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Management and work methods with EO
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Appointment of an occupational health physician
Number of subjects: 120
Study: 9238887

Group type: EXPERIMENTAL
Intervention: Dentrust toothbrush
Number of subjects: 93

Group type: COMPARATOR
Intervention: Oral-B toothbrush
Number of subjects: 93
Study: 1346268

Group type: EXPERIMENTAL
Intervention: Epanolol (200 mg daily)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Metoprolol (200 mg daily)
Number of subjects: 114
Study: 6384637

Group type: EXPERIMENTAL
Intervention: Pindolol eye drops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 0
Study: 30072789

Group type: EXPERIMENTAL
Intervention: Direct composite resin restorations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indirect composite resin restorations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inlay restorations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Onlay restorations
Number of subjects: 0
Study: 27473613

Group type: EXPERIMENTAL
Intervention: 90-minute after-school physical activity club offered 3 days a week
Number of subjects: 1519

Group type: EXPERIMENTAL
Intervention: 90-minute after-school physical activity club
Number of subjects: 1519
Study: 25147013

Group type: EXPERIMENTAL
Intervention: Balneohydrotherapy (18 days of treatment including Kneipp therapy, walking in a mineral water pool, massage, and bathing in a mineral water tub)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 99
Study: 22264996

Group type: EXPERIMENTAL
Intervention: LPS (0.4 ng/kg)
Number of subjects: 11
Study: 20347063

Group type: EXPERIMENTAL
Intervention: Emotional words (taboo and negative) presented from the right speaker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotional words (taboo and negative) presented from the left speaker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive words
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lateralized beep detection
Number of subjects: 0
Study: 18381581

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 15642562

Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 8341

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8341
Study: 12558207

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (intervention brochure)
Number of subjects: 2966

Group type: COMPARATOR
Intervention: Standard invitation (control group)
Number of subjects: 2966
Study: 11693946

Group type: EXPERIMENTAL
Intervention: Gas chromatography‐mass spectrometry (GC‐MS) analysis
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Enzyme-linked immunosorbent assay (ELISA) for mercapturate metabolic product
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Triazine in water ELISA
Number of subjects: 99
Study: 8925544

Group type: EXPERIMENTAL
Intervention: Heparan sulphate (100 mg/day for 3-4 months)
Number of subjects: 102
Study: 1531468

Group type: EXPERIMENTAL
Intervention: Laparoscopic salpingostomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conservative surgical approach
Number of subjects: 0
Study: 6418441

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (2 mg 4-times daily)
Number of subjects: 31
Study: 31332603

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided subclavian vein catheterization
Number of subjects: 170

Group type: COMPARATOR
Intervention: Fluoroscopy-guided subclavian vein catheterization
Number of subjects: 170
Study: 28145769

Group type: EXPERIMENTAL
Intervention: Baseline peer victimization
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Lower social support from classmates
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Parental anxiety severity
Number of subjects: 121
Study: 26363305

Group type: EXPERIMENTAL
Intervention: Single-session intervention
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Six sessions of cognitive therapy
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Motivational therapy
Number of subjects: 99
Study: 24232449

Group type: EXPERIMENTAL
Intervention: Intervention hospitals (targeted behavioral intervention)
Number of subjects: 557

Group type: COMPARATOR
Intervention: Control hospitals (no intervention)
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Patients arriving by ambulance
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Patients with severe strokes
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: Postintervention period
Number of subjects: 557
Study: 22246780

Group type: EXPERIMENTAL
Intervention: Not exposed to SHS for 6 months (Group 1)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Exposed to SHS for 6 months (Group 2)
Number of subjects: 498
Study: 20304772

Group type: EXPERIMENTAL
Intervention: Airway clearance therapy (ACT)
Number of subjects: 153
Study: 17559610

Group type: EXPERIMENTAL
Intervention: Adapted arthritis self-management programme with added exercise component
Number of subjects: 120

Group type: COMPARATOR
Intervention: Joint protective practice
Number of subjects: 120
Study: 10727589

Group type: EXPERIMENTAL
Intervention: Prednisone (1 or 2 mg/kg body weight)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study: 9403265

Group type: EXPERIMENTAL
Intervention: Povidone-iodine sugar ointment (P-1, P-2, P-3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available product (UP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Povidone-iodine sugar ointment (P-3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Povidone-iodine sugar ointment (P-1, P-2)
Number of subjects: 0
Study: 1438106

Group type: COMPARATOR
Intervention: Advice Only (AO)
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Counseling Intervention (CI)
Number of subjects: 1286

Group type: EXPERIMENTAL
Intervention: Counseling plus Nicotine-Containing Gum (CI+NCG)
Number of subjects: 1286
Study: 3800432

Group type: COMPARATOR
Intervention: 0 ppm nitrogen dioxide (NO2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.3 ppm nitrogen dioxide (NO2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 1.0 ppm nitrogen dioxide (NO2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 3.0 ppm nitrogen dioxide (NO2)
Number of subjects: 21
Study: 30290905

Group type: EXPERIMENTAL
Intervention: Thalidomide (200-400 mg, orally on days 1-28) during induction and maintenance therapy.
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Thalidomide maintenance therapy (50 mg, orally, daily).
Number of subjects: 536

Group type: COMPARATOR
Intervention: Interferon alfa (3 × 10^6 international units, subcutaneously, three times weekly) during maintenance therapy.
Number of subjects: 536
Study: 26777774

Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 24503927

Group type: EXPERIMENTAL
Intervention: Triflusal
Number of subjects: 441

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 441
Study: 22801271

Group type: EXPERIMENTAL
Intervention: Test formulation (national made atorvastatin)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation (imported atorvastatin)
Number of subjects: 24
Study: 20430288

Group type: EXPERIMENTAL
Intervention: TCM acupuncture
Number of subjects: 51

Group type: COMPARATOR
Intervention: Shallow needle (sham) acupuncture
Number of subjects: 51
Study: 18339796

Group type: EXPERIMENTAL
Intervention: Lateral raise
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Upright row
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Shrug
Number of subjects: 12
Study: 15735110

Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient supplement (DMM)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Daily placebo supplement (P)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement 1 day of the week and placebo on other days (WMM)
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Daily iron supplement (DI)
Number of subjects: 265
Study: 12908647

Group type: EXPERIMENTAL
Intervention: Vocational training by a work co-ordinator
Number of subjects: 1037

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 1037
Study: 10745611

Group type: EXPERIMENTAL
Intervention: Percutaneous collagen hemostasis device
Number of subjects: 165
Study: 8916595

Group type: EXPERIMENTAL
Intervention: Pilocarpine 1% and Clonidine 0.125% combination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pilocarpine 1%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clonidine 0.125%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 0
Study: 1873286

Group type: EXPERIMENTAL
Intervention: Mucosal petechiometry
Number of subjects: 0

Group type: COMPARATOR
Intervention: Template bleeding time
Number of subjects: 0
Study: 30624666

Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced, high-protein (CRHP) diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional recommended (CR) diet
Number of subjects: 10
Study: 28319550

Group type: EXPERIMENTAL
Intervention: Basal infusion (8 mL/h)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Bolus doses (24 mL every 3 hours for a total of 2 bolus doses)
Number of subjects: 24
Study: 25688817

Group type: EXPERIMENTAL
Intervention: Exercise intervention (n = 19)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control arm (n = 16)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 35
Study: 24047421

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg/day (N=25)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/day (N=24)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (N=29)
Number of subjects: 90
Study: 21861972

Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (performed a mean of 8.3 ± 4.1 days before injection)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intravitreal triamcinolone acetonide injection (control group)
Number of subjects: 31
Study: 20007081

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 86
Study: 17491224

Group type: EXPERIMENTAL
Intervention: 4F catheters
Number of subjects: 177

Group type: COMPARATOR
Intervention: 6F catheters
Number of subjects: 177
Study: 15773821

Group type: EXPERIMENTAL
Intervention: Cluster headache (CH)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Paroxysmal hemicrania (PH)
Number of subjects: 62
Study: 12096335

Group type: EXPERIMENTAL
Intervention: IPCfoot
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: IPCcalf
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: IPCfoot+calf
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: IPCfoot+calf and IPCcalf
Number of subjects: 78
Study: 9928687

Group type: EXPERIMENTAL
Intervention: Ketorolac (60 mg intramuscular injection)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Meperidine (100 to 150 mg intramuscular injection based on weight)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 70

Group type: COMPARATOR
Intervention: Meperidine
Number of subjects: 70
Study: 7569822

Group type: EXPERIMENTAL
Intervention: Open coping patterns
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Less social support
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: High degree of covert coping (among furniture removers)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: High degree of sleep disturbance
Number of subjects: 320
Study: 2373126

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 9
Study: 7233551

Group type: COMPARATOR
Intervention: Niridazole (7-day treatment)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Praziquantel (1-day treatment, 2 x 30 mg per kg)
Number of subjects: 45
Study: 30085011

Group type: EXPERIMENTAL
Intervention: Housing First intervention
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Educational level equal or less than eighth grade
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: History of incarceration
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Substance dependence
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Injection drug use during one month prior to recruitment
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Having a psychotic disorder
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Age < 25
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Blood tests performed on 30 participants
Number of subjects: 497
Study: 28452603

Group type: EXPERIMENTAL
Intervention: Music therapy during surgery (Group M)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No music during surgery (Group C)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Music therapy (Group M)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No music (Group C)
Number of subjects: 140
Study: 25622070

Group type: EXPERIMENTAL
Intervention: Low stigma-reducing condition
Number of subjects: 330

Group type: COMPARATOR
Intervention: High stigma-reducing condition
Number of subjects: 330
Study: 24343961

Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT) for 12 months
Number of subjects: 89
Study: 21890884

Group type: EXPERIMENTAL
Intervention: Propofol in cyclodextrin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propofol in lipid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other endpoints (sedation)
Number of subjects: 0
Study: 19478247

Group type: EXPERIMENTAL
Intervention: Ministry of Health training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 16903592

Group type: EXPERIMENTAL
Intervention: Rolling needle therapy at the Urinary Bladder Channel line 1 and 2 and the Governor Vessel for 4 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Clonopin 4-6 mg for 4 weeks
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Rolling needle therapy after 3 months follow-up
Number of subjects: 180

Group type: COMPARATOR
Intervention: Clonopin after 3 months follow-up
Number of subjects: 180
Study: 14684393

Group type: EXPERIMENTAL
Intervention: Orlistat (120 mg 3 times daily)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 11339779

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (SA) with 50 mg of 1% lidocaine
Number of subjects: 84

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia (SA)
Number of subjects: 84
Study: 10423596

Group type: EXPERIMENTAL
Intervention: 10 mg ebastine after overnight fast
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 mg ebastine after low-fat breakfast
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 10 mg ebastine after high-fat breakfast
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 20 mg ebastine after overnight fast
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 20 mg ebastine after high-fat breakfast
Number of subjects: 30

Group type: COMPARATOR
Intervention: Low-fat meal
Number of subjects: 30

Group type: COMPARATOR
Intervention: High-fat meal
Number of subjects: 30
Study: 7925757

Group type: EXPERIMENTAL
Intervention: Menopausal changes in body composition and energy expenditure
Number of subjects: 0
Study: 3295883

Group type: EXPERIMENTAL
Intervention: Adenosine (0.104 +/- 0.024 mg/kg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Verapamil (8.4 +/- 3.4 mg IV)
Number of subjects: 44
Study: 29073351

Group type: EXPERIMENTAL
Intervention: Belimumab at 10 mg/kg intravenously
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 27256562

Group type: EXPERIMENTAL
Intervention: Healthy group (instructed to choose foods representing a healthy diet)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (instructed to serve themselves foods they would eat on a normal day)
Number of subjects: 187
Study: 24731832

Group type: EXPERIMENTAL
Intervention: Moderate altitude hiking (1700 m)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Low altitude hiking (200 m)
Number of subjects: 71
Study: 23899530

Group type: EXPERIMENTAL
Intervention: Sunitinib at 37.5mg daily until progression or a maximum of 6 months (arm B)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Observation (arm A)
Number of subjects: 56
Study: 20839434

Group type: EXPERIMENTAL
Intervention: Dexamethasone (20 mg) intravenously injected before 1 hour of cement injection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (2 mL) intravenously injected
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dexamethasone (20 mg) intravenously injected
Number of subjects: 40
Study: 17426744

Group type: EXPERIMENTAL
Intervention: Spot urine samples
Number of subjects: 154

Group type: COMPARATOR
Intervention: 24‐h urine samples
Number of subjects: 154
Study: 15837829

Group type: EXPERIMENTAL
Intervention: Red wine (375 mL; 39 grams alcohol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beer (1125 mL; 41 grams alcohol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control-abstinence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: De-alcoholized red wine (375 mL)
Number of subjects: 0
Study: 11796680

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Flexibility-control
Number of subjects: 30
Study: 10467610

Group type: EXPERIMENTAL
Intervention: TPN as adjunct of medical therapy (Group I)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: TPN for in-hospital supportive care (Group II)
Number of subjects: 26
Study: 7592151

Group type: EXPERIMENTAL
Intervention: Stimulus-choice procedure with two treatments based on Premack's principle
Number of subjects: 1
Study: 1981422

Group type: EXPERIMENTAL
Intervention: Extra guidance from a trained nurse
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine information given by the physician during the medical visit
Number of subjects: 50
Study: 6794419

Group type: EXPERIMENTAL
Intervention: Metoprolol Durules administered once daily at a daily dosage of 200 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Metoprolol tablets administered twice daily at a daily dosage of 200 mg
Number of subjects: 17
Study: 31521424

Group type: EXPERIMENTAL
Intervention: Educational videos
Number of subjects: 207

Group type: COMPARATOR
Intervention: Routine care (no educational videos)
Number of subjects: 207
Study: 29709606

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (NSPT) combined with antimicrobial photodynamic therapy (aPDT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-surgical periodontal therapy (NSPT)
Number of subjects: 12
Study: 27589225

Group type: EXPERIMENTAL
Intervention: OPTIA
Number of subjects: 23

Group type: COMPARATOR
Intervention: COBE
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both
Number of subjects: 23
Study: 25298820

Group type: EXPERIMENTAL
Intervention: CDS tool
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Completion of risk prediction and bundled order set components
Number of subjects: 168
Study: 22437556

Group type: EXPERIMENTAL
Intervention: Rice-based lunch meals fortified with low-iron (6.25 mg) micronutrients
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Rice-based lunch meals fortified with high-iron (12.5 mg) micronutrients
Number of subjects: 258

Group type: COMPARATOR
Intervention: Identical meals with unfortified rice
Number of subjects: 258
Study: 20357328

Group type: EXPERIMENTAL
Intervention: Early reconstruction (< two weeks)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Delayed reconstruction (> four to six weeks)
Number of subjects: 105